Dunbar CE, High KA, Joung JK, Kohn DB, Ozawa K, Sadelain M
The regulatory environment continues to evolve, and patients should stay informed about current availability through their prescribers and pharmacies
Final Verdict: Research Comparison Feature Tirzepatide Retatrutide Receptor Targets GLP-1, GIP GLP-1, GIP, Glucagon Half-Life ~5 Days ~6 Days Max Published Weight Loss ~21% (72w) ~24% (48w) Liver Fat Reduction Moderate/High Extreme Primary Research Focus Glycemic Control Metabolic Reset / REE Future Outlook: Post-2025 Research Landscape As we look toward 2026 and beyond, the data from the Phase 3 TRIUMPH trials will likely solidify retatrutides position in the metabolic research hierarchy
CJC-1295's advantage is its enhanced stability and longer duration of action, producing more robust GH elevation with less frequent dosing
If youre interested in testing out a couple of supplements, the company also offers sample packs of complementary products
